PLUS1
1.77
-0.02 (-1.12%)
-0.02 (-1.12%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 41,883 |
|
|||||
| News | - | ||||||
| Day High | 1.82 | Low High |
|||||
| Day Low | 1.76 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Allarity Therapeutics Inc | ALLR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.02 | -1.12% | 1.77 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.82 | 1.76 | 1.82 | 1.77 | 1.79 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 318 | 41,883 | $ 1.76 | $ 73,814 | - | 1.10 - 17.45 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:55:15 | 1 | $ 1.73 | USD |
Period:
Draw Mode:
Allarity Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 16.43M | 9.28M | 8.03M | $ - | $ - | -4.19 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 0.50% |
Allarity Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALLR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.78 | 1.87 | 1.74 | 1.80 | 61,044 | -0.01 | -0.56% |
| 1 Month | 2.62 | 3.38 | 1.54 | 2.42 | 130,096 | -0.85 | -32.44% |
| 3 Months | 2.12 | 3.38 | 1.10 | 2.38 | 155,393 | -0.35 | -16.51% |
| 6 Months | 12.00 | 12.8576 | 1.10 | 3.19 | 117,748 | -10.23 | -85.25% |
| 1 Year | 13.18 | 17.45 | 1.10 | 3.37 | 117,383 | -11.41 | -86.57% |
| 3 Years | 13.18 | 17.45 | 1.10 | 3.37 | 117,383 | -11.41 | -86.57% |
| 5 Years | 13.18 | 17.45 | 1.10 | 3.37 | 117,383 | -11.41 | -86.57% |
Allarity Therapeutics Description
| Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations. |
